Science Explorer Back to mapMap
Discussion
Topic · Molecular Medicine

Curcumin's Biomedical Applications

Curcumin's Biomedical Applications is a research topic within Molecular Medicine. Science Explorer counts 13k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the bioavailability, health effects, and therapeutic potential of curcumin, a natural compound with antioxidant, anti-inflammatory, and potential anticancer properties. The papers cover various aspects including its molecular targets, clinical trials, nanoparticle encapsulation for improved delivery, neuroprotective effects, and pharmacokinetics. The research explores the application of curcumin in the prevention and treatment of various diseases such as cancer, neurodegenerative diseases, cardiovascular diseases, and diabetes.

  • Curcumin
  • Bioavailability
  • Antioxidant
  • Inflammation
  • Cancer
  • Therapeutic
  • Nanoparticles
  • Clinical Trials
  • Neuroprotective
  • Pharmacokinetics
Research works
13k
fractional, since 1950
In the world top 10%
1.4k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+38%
the tick is no change
Largest producer
China
31% of the 10 largest, 2022-now
Curcumin's Biomedical Applications

Which countries lead Curcumin's Biomedical Applications research?

By volume, China and India publish the most (1.1k and 908 works in 2022-now).

By volume, 2022-now

  1. 1 China 1.1k works
  2. 2 India 908 works
  3. 3 Iran 400 works
  4. 4 United States 253 works
  5. 5 Indonesia 248 works
  6. 6 Egypt 237 works
  7. 7 Türkiye 143 works
  8. 8 Saudi Arabia 129 works
  9. 9 Brazil 124 works
  10. 10 South Korea 104 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 30.7%India: 24.7%Iran: 10.9%United States: 6.9%6 others listed: 26.8%31%largest
China1,126 · 30.7%India908 · 24.7%Iran400 · 10.9%United States253 · 6.9%6 others listed985 · 26.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Curcumin's Biomedical Applications research?

By volume in 2022-now, Islamic Azad University, Tehran publishes the most Curcumin's Biomedical Applications research, followed by Tabriz University of Medical Sciences and Mashhad University of Medical Sciences.

By volume, 2022-now

  1. 1 Islamic Azad University, TehranIran 56 works
  2. 2 Tabriz University of Medical SciencesIran 34 works
  3. 3 Mashhad University of Medical SciencesIran 33 works
  4. 4 Saveetha UniversityIndia 32 works
  5. 5 Cairo UniversityEgypt 30 works
  6. 6 King Saud UniversitySaudi Arabia 28 works
  7. 7 Wenzhou Medical UniversityChina 20 works
  8. 8 Chengdu University of Traditional Chinese MedicineChina 19 works
  9. 9 Russian Academy of SciencesRussia 18 works
  10. 10 Tehran University of Medical SciencesIran 18 works

Who are the leading researchers in Curcumin's Biomedical Applications?

The most-cited researchers publishing on Curcumin's Biomedical Applications include Amirhossein Sahebkar, Kai You Wang and Maciej Banach.

  1. 1 Amirhossein Sahebkar Iran 258k citations
  2. 2 Kai You Wang China 224k citations
  3. 3 Maciej Banach Poland 204k citations
  4. 4 Philip Scheltens Netherlands 194k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Curcumin's Biomedical Applications?

The most cited paper in Curcumin's Biomedical Applications is "Bioavailability of Curcumin: Problems and Promises" (Preetha Anand, Ajaikumar Bahulayan Kunnumakkara, Robert Alan Newman et al., 2007), with 5,518 citations. Next come "Role of reactive oxygen species (ROS) in apoptosis induction" (2,787) and "Curcumin: A Review of Its Effects on Human Health" (2,687).

Most cited papers
#PaperReleasedCitations
1 Bioavailability of Curcumin: Problems and Promises Preetha Anand, Ajaikumar Bahulayan Kunnumakkara, Robert Alan Newman et al. · Molecular Pharmaceutics 14 Nov 2007 5,518
2 Role of reactive oxygen species (ROS) in apoptosis induction Hans‐Uwe Simon, Abdulla Haj-Yehia, Francesca Levi‐Schaffer · APOPTOSIS Nov 2000 2,787
3 Curcumin: A Review of Its Effects on Human Health Susan Joyce Hewlings, Douglas Kalman · Foods Open access 22 Oct 2017 2,687
4 Anticancer potential of curcumin: preclinical and clinical studies. Bharat Bhushan Aggarwal, Anushree Jai Kumar, Alok Chandra Bharti · PubMed May 2003 2,576
5 Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo Fusheng Yang, Giselle P. Lim, Aynun Nahar Begum et al. · Journal of Biological Chemistry Open access 8 Dec 2004 2,331
All 100 most cited papers, with filters and sorting

Where is Curcumin's Biomedical Applications research done?

The largest centres of Curcumin's Biomedical Applications research in 2022-now are Tehran (Iran), Beijing (China), Chennai (India) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Mashhad and Tabriz.

Largest cities, 2022-now

  1. 1 TehranIran 111 works
  2. 2 BeijingChina 95 works
  3. 3 ChennaiIndia 76 works
  4. 4 GuangzhouChina 66 works
  5. 5 CairoEgypt 60 works
  6. 6 GizaEgypt 58 works
  7. 7 HangzhouChina 55 works
  8. 8 ShanghaiChina 51 works
  9. 9 ChengduChina 51 works
  10. 10 RiyadhSaudi Arabia 48 works

Where it is the local speciality

  1. MashhadIR · 45.5 works18×
  2. TabrizIR · 42.0 works13×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Curcumin's Biomedical Applications than the world average.

See Curcumin's Biomedical Applications on the map

Where is the best place to study Curcumin's Biomedical Applications?

Among universities, judged by research, Nanchang University, Tabriz University of Medical Sciences and Mashhad University of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 15.47%fractional works in this field (log) →share of work in the world top 10% →Nanchang UniversityChengdu University o…Mashhad University o…Tabriz University of…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Nanchang UniversityChina 67.027.3%4.5×14 +66.7%
2Tabriz University of Medical SciencesIran 65.411.9%29.3×34 +17.3%
3Mashhad University of Medical SciencesIran 62.214.6%32.8×33 -4.3%
4Chengdu University of Traditional Chinese MedicineChina 61.018.9%17.5×19 +219.3%
5Sichuan UniversityChina 60.329.3%1.6×16 +67.7%
6Islamic Azad University, TehranIran 59.36.7%7.8×56 +23.2%
7Cairo UniversityEgypt 59.213.2%9.1×30 +42.5%
8King Saud UniversitySaudi Arabia 56.47.3%6.5×28 +102.6%
9Saveetha UniversityIndia 55.69.6%7.8×32 +243.6%
10Wenzhou Medical UniversityChina 52.915.9%9.3×20 +30.8%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Curcumin's Biomedical Applications, country by country

Is Curcumin's Biomedical Applications research growing?

Output in 2022-2025 was 38% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Curcumin's Biomedical Applications.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Curcumin's Biomedical Applications as a percentage of every work published that year, 0.020% in 2024.

still counting0.010%0.020%0.030%Curcumin's Biomedical Applications0.023% in 202519801990200020102020

Fractional works of Curcumin's Biomedical Applications over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Curcumin's Biomedical Applications10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Curcumin's Biomedical Applications. Posts are plain text and can be reported.